Le Lézard
Classified in: Health
Subject: AVO

CompassCare Remembers Chris Slattery, a Dedicated Advocate for Life


Remembering a pro-life pioneer.

ROCHESTER, N.Y., Nov. 22, 2023 /PRNewswire-PRWeb/ -- CompassCare, a company that provides pregnancy services to many in the United States, would like to take the time to remember an advocate in the pro-life community, Chris Slattery.

On the early morning of November 22, 2023, at Calvary Hospice in the Bronx, we said farewell to Chris Slattery, a tireless pro-life pioneer who dedicated 40 years to the cause, leaving us at the age of 68. Chris embarked on his mission in 1979 in the wake of the legalization of abortion, making a profound impact in the heart of New York City, often referred to as the American abortion capital.

Armed with his advertising skills from Boston College, Chris founded the pregnancy center network, Expectant Mother Care, later known as EMC Frontline, which blossomed to include 14 locations across the five boroughs. In a recent interview, Chris candidly reflected on his journey, stating, "It was a management logistical nightmare... It was a bold act of daring. I always thought that if I had millions, I could have done more."

Surrounded by his loving wife and children, along with the support of numerous priests and bishops, Chris passed away, leaving behind a legacy fueled by his unwavering belief in the sanctity of human life. He once expressed, "The most precious beings in the world are human beings, made in [God's] likeness and image, with an eternal soul."

Chris' innovative spirit led to the early adoption of ultrasound scans in 1986, two decades before many pregnancy centers considered using this technology. He extended his reach to the streets with mobile medical vans, a concept now embraced nationwide. Ultrasound imaging, championed by Chris, provides women considering abortion with true informed consent, humanizing the unborn child and helping them comprehend the profound impact of abortion on both themselves and their preborn babies.

In his later years, Chris faced opposition from the abortion industry and pro-abortion politicians, but his resilience remained unyielding. Even during his battle with cancer, he passed on his leadership mantle to Rev. Jim Harden, CEO of CompassCare, another New York-based pro-life medical network. Rev. Harden remarked, "Chris Slattery's no-nonsense style offended the sensibilities of many, but he was willing to offend to mend the wound of abortion."

In his last public interview, Chris, when asked for advice to the pro-life community, emphasized the need to "figure out how to save babies." He urged proactive responses, intelligence, savvy, and well-placed financial donations.

To honor Chris Slattery's memory, a $500,000 dollar-for-dollar matching fund has been established to continue his pro-life work in NYC. Visit https://www.compasscarecommunity.com/nyc/ to contribute to saving women and preborn children from abortion in memory of Chris Slattery's impactful legacy.

"The most precious beings in the world are human beings, made in [God's] likeness and image, with an eternal soul."

Media Contact

Gerald McGlothlin, Special Guests, 919-437-0001, [email protected], http://www.specialguests.com

 

SOURCE Special Guests


These press releases may also interest you

at 08:05
Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, today announced additional favorable safety and efficacy data from the company's ongoing Phase 1b/2 clinical trial...

at 08:05
Xcell Biosciences Inc. (Xcellbio), an innovative technology company focused on cell and gene therapy manufacturing applications, and AmplifyBio, a rapidly growing contract development and manufacturing organization, today announced the launch of a...

at 08:05
GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, today announced upcoming presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago, Illinois...

at 08:05
Kiromic BioPharma, Inc. ("Kiromic" or the "Company") announces that UPMC in Pittsburgh, Pennsylvania has been activated as the fourth clinical trial site in the Deltacel-01 Phase 1 trial evaluating Deltaceltm (KB-GDT-01), Kiromic's allogeneic,...

at 08:03
JPMA Cares, the nonprofit foundation of the juvenile products industry, announced it's launching a Safe Sleep Campaign in partnership with Cribs for Kids, First Candle, and Safe Kids Worldwide. The campaign aims to deliver easy-to-understand,...

at 08:00
MedISAO, an organization composed of members of the medical device manufacturer community dedicated to improving medical device security through education, awareness, and advocacy, announced today its endorsement by the Food and Drug Administration...



News published on and distributed by: